Literature DB >> 16030203

Transcriptional analysis of the Bacillus anthracis capsule regulators.

Melissa Drysdale1, Agathe Bourgogne, Theresa M Koehler.   

Abstract

The poly-d-glutamic acid capsule of Bacillus anthracis is essential for virulence. Control of capsule synthesis occurs at the level of transcription and involves positive regulation of the capsule biosynthetic operon capBCAD by a CO2/bicarbonate signal and three plasmid-borne regulators: atxA, acpA, and acpB. Although the molecular mechanism for control of cap transcription is unknown, atxA affects cap expression via positive control of acpA and acpB, two genes with partial functional similarity. Transcriptional analyses of a genetically complete strain indicate that capB expression is several hundred-fold higher during growth in 5% CO2 compared to growth in air. atxA was expressed appreciably during growth in air and induced only 2.5-fold by CO2. In contrast, expression of acpA and acpB was induced up to 23-fold and 59-fold, respectively, by CO2. The 5'-end mapping of gene transcripts revealed atxA-regulated and atxA-independent apparent transcription start sites for capB, acpA, and acpB. Transcripts mapping to all atxA-regulated start sites were increased during growth in elevated CO2. The acpA gene has one atxA-regulated and one atxA-independent start site. acpB lies downstream of capBCAD. A single atxA-independent start site maps immediately upstream of acpB. atxA-mediated control of acpB appears to occur via transcriptional read-through from atxA-dependent start sites 5' of capB. One atxA-independent and two atxA-regulated start sites map upstream of capB. Transcription from the atxA-regulated start sites of capBCAD was reduced significantly in an acpA acpB double mutant but unaffected in mutants with deletion of only acpA or acpB, in agreement with the current model for epistatic relationships between the regulators.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16030203      PMCID: PMC1196023          DOI: 10.1128/JB.187.15.5108-5114.2005

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  19 in total

1.  atxA controls Bacillus anthracis capsule synthesis via acpA and a newly discovered regulator, acpB.

Authors:  Melissa Drysdale; Agathe Bourgogne; Susan G Hilsenbeck; Theresa M Koehler
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

2.  Transcriptional antitermination in the bgl operon of E. coli is modulated by a specific RNA binding protein.

Authors:  F Houman; M R Diaz-Torres; A Wright
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

3.  Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax.

Authors:  Melissa Drysdale; Sara Heninger; Julie Hutt; Yahua Chen; C Rick Lyons; Theresa M Koehler
Journal:  EMBO J       Date:  2004-12-16       Impact factor: 11.598

4.  Transcriptional regulation of the protective antigen gene of Bacillus anthracis.

Authors:  J M Bartkus; S H Leppla
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

5.  Molecular characterization and protein analysis of the cap region, which is essential for encapsulation in Bacillus anthracis.

Authors:  S Makino; I Uchida; N Terakado; C Sasakawa; M Yoshikawa
Journal:  J Bacteriol       Date:  1989-02       Impact factor: 3.490

6.  Mry, a trans-acting positive regulator of the M protein gene of Streptococcus pyogenes with similarity to the receptor proteins of two-component regulatory systems.

Authors:  J Perez-Casal; M G Caparon; J R Scott
Journal:  J Bacteriol       Date:  1991-04       Impact factor: 3.490

7.  The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria.

Authors:  Timothy D Read; Scott N Peterson; Nicolas Tourasse; Les W Baillie; Ian T Paulsen; Karen E Nelson; Hervé Tettelin; Derrick E Fouts; Jonathan A Eisen; Steven R Gill; Erik K Holtzapple; Ole Andreas Okstad; Erlendur Helgason; Jennifer Rilstone; Martin Wu; James F Kolonay; Maureen J Beanan; Robert J Dodson; Lauren M Brinkac; Michelle Gwinn; Robert T DeBoy; Ramana Madpu; Sean C Daugherty; A Scott Durkin; Daniel H Haft; William C Nelson; Jeremy D Peterson; Mihai Pop; Hoda M Khouri; Diana Radune; Jonathan L Benton; Yasmin Mahamoud; Lingxia Jiang; Ioana R Hance; Janice F Weidman; Kristi J Berry; Roger D Plaut; Alex M Wolf; Kisha L Watkins; William C Nierman; Alyson Hazen; Robin Cline; Caroline Redmond; Joanne E Thwaite; Owen White; Steven L Salzberg; Brendan Thomason; Arthur M Friedlander; Theresa M Koehler; Philip C Hanna; Anne-Brit Kolstø; Claire M Fraser
Journal:  Nature       Date:  2003-05-01       Impact factor: 49.962

8.  Cloning and characterization of a gene whose product is a trans-activator of anthrax toxin synthesis.

Authors:  I Uchida; J M Hornung; C B Thorne; K R Klimpel; S H Leppla
Journal:  J Bacteriol       Date:  1993-09       Impact factor: 3.490

9.  Effect of the lower molecular capsule released from the cell surface of Bacillus anthracis on the pathogenesis of anthrax.

Authors:  Sou-Ichi Makino; Masahisa Watarai; Hyeng-Il Cheun; Toshikazu Shirahata; Ikuo Uchida
Journal:  J Infect Dis       Date:  2002-06-27       Impact factor: 5.226

10.  Demonstration of a capsule plasmid in Bacillus anthracis.

Authors:  B D Green; L Battisti; T M Koehler; C B Thorne; B E Ivins
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

View more
  26 in total

1.  Genome engineering in Bacillus anthracis using Cre recombinase.

Authors:  Andrei P Pomerantsev; Ramakrishnan Sitaraman; Craig R Galloway; Violetta Kivovich; Stephen H Leppla
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Glucose-dependent activation of Bacillus anthracis toxin gene expression and virulence requires the carbon catabolite protein CcpA.

Authors:  Christina Chiang; Cristina Bongiorni; Marta Perego
Journal:  J Bacteriol       Date:  2010-10-22       Impact factor: 3.490

3.  Dual promoters control expression of the Bacillus anthracis virulence factor AtxA.

Authors:  Cristina Bongiorni; Tatsuya Fukushima; Adam C Wilson; Christina Chiang; M Cecilia Mansilla; James A Hoch; Marta Perego
Journal:  J Bacteriol       Date:  2008-08-01       Impact factor: 3.490

Review 4.  The Bacillus cereus Group: Bacillus Species with Pathogenic Potential.

Authors:  Monika Ehling-Schulz; Didier Lereclus; Theresa M Koehler
Journal:  Microbiol Spectr       Date:  2019-05

5.  Expression of the pyr operon of Lactobacillus plantarum is regulated by inorganic carbon availability through a second regulator, PyrR2, homologous to the pyrimidine-dependent regulator PyrR1.

Authors:  Florence Arsène-Ploetze; Valérie Kugler; Jan Martinussen; Françoise Bringel
Journal:  J Bacteriol       Date:  2006-10-13       Impact factor: 3.490

Review 6.  Assembly and Function of the Bacillus anthracis S-Layer.

Authors:  Dominique Missiakas; Olaf Schneewind
Journal:  Annu Rev Microbiol       Date:  2017-09-08       Impact factor: 15.500

7.  Bacillus anthracis virulence regulator AtxA: oligomeric state, function and CO(2) -signalling.

Authors:  Troy G Hammerstrom; Jung Hyeob Roh; Edward P Nikonowicz; Theresa M Koehler
Journal:  Mol Microbiol       Date:  2011-10-10       Impact factor: 3.501

8.  Poly-gamma-glutamate capsule-degrading enzyme treatment enhances phagocytosis and killing of encapsulated Bacillus anthracis.

Authors:  Angelo Scorpio; Donald J Chabot; William A Day; David K O'brien; Nicholas J Vietri; Yoshifumi Itoh; Mansour Mohamadzadeh; Arthur M Friedlander
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

9.  The roles of AtxA orthologs in virulence of anthrax-like Bacillus cereus G9241.

Authors:  Jennifer M Scarff; Malik J Raynor; Yuliya I Seldina; Christy L Ventura; Theresa M Koehler; Alison D O'Brien
Journal:  Mol Microbiol       Date:  2016-09-04       Impact factor: 3.501

10.  Bicarbonate enhances expression of the endocarditis and biofilm associated pilus locus, ebpR-ebpABC, in Enterococcus faecalis.

Authors:  Agathe Bourgogne; L Charlene Thomson; Barbara E Murray
Journal:  BMC Microbiol       Date:  2010-01-21       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.